Calico Life Sciences LLC Report issue

For profit Phase 1 Phase 3
Founded: San Francisco California United States (2013)

Organization Overview

First Clinical Trial
2020
NCT04417465
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Calico Life Sciences LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

abbv-cls-7262 (5 trials)

Drugs in Phase 1 Trials (2)

abbv-cls-484 (1 trial)

abbv-cls-579 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasm Metastasis (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 3